Skip to main content
NBIX
NASDAQ Life Sciences

Neurocrine Posts $3.29 Q3 Adjusted EPS as Revenue Jumps 41%

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$157.48
Mkt Cap
$14.775B
52W Low
$122.138
52W High
$186.12
52W Position info
29% above low
Off High info
15% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

NBIX sits 29% above its 52-week low of $122.138.

Summary

Neurocrine reported Q3 adjusted EPS of $3.29, landing alongside the 8-K and 10-Q filed this evening showing revenue of $1.123 billion, up 41%, and net income of $206.5 million. INGREZZA drove $801 million of sales. The adjusted EPS figure is the cleanest read on underlying profitability and comes in as a fresh number beyond the revenue and net income already disclosed. The company also posted 3Q EPS of $1.96. Watch the full-year INGREZZA guidance and the Alvogen ANDA against VYKAT XR disclosed in the 10-Q as the two swing factors for the stock.

At the time of this announcement, NBIX was trading at $157.48 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $14.8B. The 52-week trading range was $122.14 to $186.12. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

NBIX - Latest Insights

NBIX
Nov 03, 2026, 2:36 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $168.29
Real-time Price: $162.00 info
Change: -$6.29 (-4%) info
Market Cap: $16.484B info
NBIX
Nov 02, 2026, 4:14 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $146.96
Real-time Price: $162.00 info
Change: +$15.04 (+10%) info
Market Cap: $16.484B info
NBIX
Nov 02, 2026, 4:11 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $145.35
Real-time Price: $162.00 info
Change: +$16.65 (+11%) info
Market Cap: $16.484B info
NBIX
Aug 26, 2026, 3:33 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $153.37
Real-time Price: $162.00 info
Change: +$8.63 (+6%) info
Market Cap: $16.484B info
NBIX
Aug 03, 2026, 7:33 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $167.40
Real-time Price: $162.00 info
Change: -$5.40 (-3%) info
Market Cap: $16.484B info